US Patent Issued to ASCENDIS PHARMA ENDOCRINOLOGY DIVISION on May 20 for "Long-acting growth hormone dosage forms with superior efficacy to daily somatropin" (Danish Inventor)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,553, issued on May 20, was assigned to ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S (Hellerup, Denmark).

"Long-acting growth hormone dosage forms with superior efficacy to daily somatropin" was invented by Kennett Sprogoe (Hellerup, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "A long-acting growth hormone or a pharmaceutical formulation comprising such long-acting growth hormone for use in a method of treating growth hormone deficiency with improved outcomes is described."

The patent was filed on March 3, 2020, under Application No. 17/310,993.

*For further information, including images, charts and tables, please visit: http://patft.uspto....